Now, BDNF is being used as a potential biomarker to dictate just how severe the mesothelioma is in a patient. Understanding how this protein works and how it can help treatment options is imperative for patients to recognize what comes next.
The BDNF Levels Can Help Understand Severity of Mesothelioma
According to the researchers involved in the latest study, higher levels of BDNF were most present in pleural mesothelioma and indications were that the higher the level of the protein, the lower the survival time for the mesothelioma patient.
Similarly, the BDNF levels can play a role in the ability to start and metastasize mesothelioma. The higher levels of BDNF mean the spreading is more prominent, which makes a new potential treatment option absolutely imperative.
Anti-BDNF Can Be Helpful
Because the high levels of BDNF lower the survival time for mesothelioma patients, the use of anti-BDNF drugs can aid in how well the existing treatment options work. There are currently 14 angiogenesis inhibitors approved by the United States Food and Drug Administration.
While this theory still needs more research, it is indicative of the potential that there may be options to fight against mesothelioma.
At Shrader & Associates, we know how important it is for those with mesothelioma to receive treatment to help improve their quality of life. While there is no cure, there is still hope to live as comfortably as possible. Part of this means seeking justice against the party responsible for the exposure to asbestos.
Our mesothelioma attorneys can explain your options and help you understand the process every step of the way so you know what to expect. Trust that we’re on your side throughout every phase and will work to protect your rights.
Call us at (713) 787-3733 today to discuss your potential case.